|
|
||||||||
a Departments of Anesthesiology/Critical Care Medicine, Environmental Health Sciences and Oncology, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21205
To determine whether chronic oxytocin pretreatment inhibits adenylyl cyclase, we compared adenylyl cyclase activity in membranes prepared from cultured, immortalized rat myometrial cells that were untreated or pretreated for 24 h with oxytocin. Chronic oxytocin pretreatment (1 x 10-5 M for 24 h) attenuated basal, guanosine triphosphate (1 x 10-5 M)-, isoproterenol (1 x 10-4 M)-, forskolin (1 x 10-5 M)-, MnCl2 (20 mM)- or NaF (1 x 10-2 M)-stimulated adenylyl cyclase activity by 27 ± 5% to 39 ± 11% (n = 6, p < 0.05). Oxytocin pretreatment for 2 h (n = 5) did not produce a significant effect. To understand the mechanism by which oxytocin pretreatment decreased activity of the adenylyl cyclase pathway, we compared effects of pretreatment with either oxytocin or phenylephrine on adenylyl cyclase activity and determined the effects of Gi inhibition and protein kinase C (PKC) depletion. Chronic (24 h) phenylephrine pretreatment (1 x 10-4 M) had effects similar to those of oxytocin pretreatment (1 x 10-5 M). PKC depletion with phorbol 12-myristate 13-acetate (1 x 10-6 M, 41 h) prevented attenuation of adenylyl cyclase activity by oxytocin pretreatment (1 x 10-5 M for 24 h). Inhibition of Gi by pertussis toxin pretreatment (1.25 µg/ml, 41 h) had no significant effect. These findings suggest that chronic oxytocin pretreatment desensitizes the adenylyl cyclase pathway by a cross-regulatory mechanism that involves activation of Gq and PKC.
2 Correspondence: Karen S. Lindeman, The Johns Hopkins Hospital, 600 North Wolfe Street, Meyer 297A, Baltimore, MD 212877294. FAX: 410 955 0299; klindema{at}welchlink.welch.jhu.edu
This article has been cited by other articles:
![]() |
V. Simon, M.-T. Robin, C. Legrand, and J. Cohen-Tannoudji Endogenous G Protein-Coupled Receptor Kinase 6 Triggers Homologous {beta}-Adrenergic Receptor Desensitization in Primary Uterine Smooth Muscle Cells Endocrinology, July 1, 2003; 144(7): 3058 - 3066. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Gogarten, K. S. Lindeman, C. A. Hirshman, and C. W. Emala Tumor Necrosis Factor Alpha Stimulates Adenylyl Cyclase Activity in Human Myometrial Cells Biol Reprod, March 1, 2003; 68(3): 751 - 757. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Oger, C. Mehats, E. Dallot, F. Ferre, and M.-J. Leroy Interleukin-1{beta} Induces Phosphodiesterase 4B2 Expression in Human Myometrial Cells through a Prostaglandin E2- and Cyclic Adenosine 3',5'-Monophosphate-Dependent Pathway J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5524 - 5531. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Emala, J. Clancy-Keen, and C. A. Hirshman Decreased adenylyl cyclase protein and function in airway smooth muscle by chronic carbachol pretreatment Am J Physiol Cell Physiol, October 1, 2000; 279(4): C1008 - C1015. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |